Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim M Ibrahim

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Molecules (Basel, Switzerland)|November 26, 2022
(<i>E</i>)-<i>N</i>-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer StudiesReda G Yousef, Hazem Elkady, Eslam B Elkaeed, et al.
RSC Advances|August 4, 2023
Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and <i>in silico</i> studiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Molecular Diversity|June 20, 2023
Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated computational analysisGideon Ampoma Gyebi, Oludare M Ogunyemi, Ibrahim M Ibrahim, et al.
Healthcare (Basel, Switzerland)|March 11, 2023
Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt IndicatorsEbtihal Al-Shareef, Lateef M Khan, Mohammed Alsieni, et al.
RSC Advances|December 20, 2023
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and <i>in vitro</i> studiesWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.
International Journal of Nanomedicine|September 10, 2019
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulationIbrahim M Ibrahim, Aditya N Bade, Zhiyi Lin, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing VirusesAaya Nassar, Ibrahim M Ibrahim, Fatma G Amin, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 29, 2023
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2Ibrahim H Eissa, Reda G Yousef, Mostafa A Asmaey, et al.
Current Cancer Drug Targets|October 2, 2025
Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFREslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Primary Care Diabetes|August 22, 2021
Unifying the diagnosis of gestational diabetes mellitus: Introducing the NPRP criteriaSuhail A R Doi, Mohammed Bashir, Michael T Sheehan, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Molecules (Basel, Switzerland)|November 26, 2022
(<i>E</i>)-<i>N</i>-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer StudiesReda G Yousef, Hazem Elkady, Eslam B Elkaeed, et al.
RSC Advances|August 4, 2023
Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and <i>in silico</i> studiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Molecular Diversity|June 20, 2023
Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated computational analysisGideon Ampoma Gyebi, Oludare M Ogunyemi, Ibrahim M Ibrahim, et al.
Healthcare (Basel, Switzerland)|March 11, 2023
Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt IndicatorsEbtihal Al-Shareef, Lateef M Khan, Mohammed Alsieni, et al.
RSC Advances|December 20, 2023
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and <i>in vitro</i> studiesWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.
International Journal of Nanomedicine|September 10, 2019
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulationIbrahim M Ibrahim, Aditya N Bade, Zhiyi Lin, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing VirusesAaya Nassar, Ibrahim M Ibrahim, Fatma G Amin, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 29, 2023
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2Ibrahim H Eissa, Reda G Yousef, Mostafa A Asmaey, et al.
Current Cancer Drug Targets|October 2, 2025
Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFREslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Primary Care Diabetes|August 22, 2021
Unifying the diagnosis of gestational diabetes mellitus: Introducing the NPRP criteriaSuhail A R Doi, Mohammed Bashir, Michael T Sheehan, et al.
Pageof 18